Back
ESC2025 Premium Access

Stroke risk in low-risk patients with atrial fibrillation on oral anticoagulation therapy: Insights from a Swedish cohort

Session: The atrial fibrillation anticoagulation puzzle: putting the pieces together
Topic: Stroke in Atrial Fibrillation
Speaker: Doctor A. Karagianni (Gothenburg, SE)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Alexia Karagianni

Carlanderska Hospital, Gothenburg (Sweden)
0 follower

7 more presentations in this session

Peridevice leak and device-related thrombus in the OPTION randomized trial

Speaker: Doctor O. wazni (Cleveland, US)

Access
Abstract
Slides
Like
Thumbnail

Impact of anaemia on OAC prescription and adverse outcomes in patients with AF and chronic HF: an analysis form a real-world observational prospective study

Speaker: Doctor M. Vitolo (Modena, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Discontinuation of oral anticoagulation and risk of worse clinical outcomes in atrial fibrillation patients: a report from the Murcia AF Project III

Speaker: Doctor J. Rivera-Caravaca (Murcia, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Impact of Clinical Complexity Features on the Risk of Major Bleeding and Subsequent Outcomes in Atrial Fibrillation Patients: A Multistate Model analysis from Two Large Observational Registries

Speaker: Doctor D. Mei (Modena, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Comparative in-hospital outcomes of acute ischemic stroke by preexisting atrial flutter or atrial fibrillation, stratified by CHADSVA score

Speaker: Doctor A. Folman (Hadera, IL)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

The atrial fibrillation anticoagulation puzzle: putting the pieces together

Speakers: Doctor A. Karagianni, Doctor O. wazni, Doctor M. Vitolo, Doctor J. Rivera-Caravaca, Doctor D. Mei...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources